(4,769) USDm

Operating Expenses for the three months ending 31 March 2022

AbbVie Operating Expenses for 3M ended Mar'22 decreased to (4,769) USDm (+723 /-13.2% q-o-q). Year-over-year, it increased to (4,769) USDm (-75/+1.6% y-o-y). The growth rate declined vs. the previous periods (CAGR +11% since 1Q'16).

Full time series as generated by EXERICA AI (29 data points have been found in 25 reports from 2015 to 2022)

Show more...